TOKYO--(BUSINESS WIRE)--Jun 2, 2026--
Hims & Hers Health, Inc. has completed its acquisition of Eucalyptus, the parent company of Juniper, marking a significant milestone in the company's global growth and its formal entry into Japan. This milestone puts the full weight of Hims & Hers’ technology, data, and clinical infrastructure behind a platform that supports weight management care for people in Japan, a market the company approaches with deep respect for its distinct healthcare values and the trust people place in those who serve them.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260602317273/en/
Juniper entered Japan in November 2023, and has since become a trusted partner to eligible local customers seeking support in their weight loss journey. In a market where people with weight-related concerns wait an average of six years to seek support for weight loss care, Juniper has built a steady customer base by offering an evidence-based path to care.
“In Japan, the need for accessible, quality weight management care has long outpaced what's available. Juniper has already started to change that,” said Andrew Dudum, co-founder and CEO of Hims & Hers. “Hims & Hers is here to accelerate that change, bringing the full scale of our platform behind a team that has already earned the trust of Japanese customers, and a shared commitment to support their lifelong health journeys.”
To best serve its customers in Japan, Hims & Hers will continue to invest in a local clinical approach, and customers will continue to be connected with Japanese providers who understand the healthcare landscape they're navigating, and bring the local expertise and clinical rigour this kind of care demands.
As Hims & Hers grows in Japan, continuity of care is a top priority. For customers who have received care through Juniper, their treatment continues uninterrupted as the brand grows. Joining Hims & Hers gives the team in Japan the backing to keep building on a model that patients have come to trust, with more resources and reach behind it.
“Trust is everything in Japanese healthcare, and it has to be earned,” said Ryan Nolan, Vice President of International at Juniper. “Juniper spent two years doing exactly that, building a standard of weight care that customers here can genuinely rely on. Now through Hims & Hers, we have the global scale and clinical depth to take that work further, providing access to the evidence-based, high-quality, judgment-free care they deserve.”
About Hims & Hers Health, Inc.
Hims & Hers is the leading health and wellness platform on a mission to help the world feel great through the power of better health. We believe how you feel in your body and mind transforms how you show up in life. That’s why we’re building a future where nothing stands in the way of harnessing this power. Hims & Hers normalizes health & wellness challenges—and innovates on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so the company provides access to personalised care designed for results. For more information, please visit www.hims.com and www.forhers.com.
Cautionary Note Regarding Forward-Looking Statements
This press release contains statements that may constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and “forward-looking information” within the meaning of applicable Japanese securities legislation (collectively, “forward-looking statements”). The forward-looking statements contained in this press release are expressly qualified by this cautionary statement and readers are cautioned not to put undue reliance on them. These forward-looking statements can be identified by the use of forward-looking terminology, including the words “believes,” “estimates,” “anticipates,” “expects,” “intends,” “plans,” “assume,” “may,” “can,” “will,” “likely,” “potential,” “occur,” “projects,” “predicts,” “continue,” “goal,” “objective,” “strategy,” “future,” “forecast,” “target,” “outlook,” “opportunity,” “project,” “confidence,” “foundation,” “groundwork,” or “could,” “should,” “would,” or, in each case, their negative or other variations or comparable terminology. There can be no assurance that actual results will not materially differ from expectations. Such statements include, but are not limited to, statements regarding Hims & Hers’ expansion into Japan, the anticipated benefits of the acquisition of Eucalyptus, the expected timing and potential launch of new products or offerings, and assumptions relating to the foregoing. These forward-looking statements are based on management’s current expectations, but actual results may differ materially due to various factors.
Forward-looking statements are neither historical facts nor assurances of future performance. Instead, the forward-looking statements contained in this press release are based on our current expectations, assumptions and beliefs concerning future developments and their potential effects on us. Future developments affecting us may not be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, uncertainties relating to the integration of Eucalyptus; our ability to successfully expand into new markets or specialties; our ability to launch new products or offerings on expected timelines or at all; expectations regarding market acceptance, user experience and customer retention; changes in healthcare, consumer protection or privacy laws; increased scrutiny from regulators; the impact of general economic, business, or financial conditions; and other factors described in the Risk Factors and other sections of our most recently filed Quarterly Report on Form 10-Q, our most recently filed Annual Report on Form 10-K, and other current and periodic reports we file from time to time with the Securities and Exchange Commission as well as additional risks and uncertainties inherent to Hims & Hers’ business, not currently known by Hims & Hers, that are out of Hims & Hers’ control or that Hims & Hers currently deems to be immaterial, which could also have a material adverse effect on Hims & Hers or on its ability to successfully integrate the acquisition of Eucalyptus.
Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. The forward-looking statements contained in this press release are made only as of the date of this press release. We undertake no obligation (and expressly disclaim any obligation) to update or revise any forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. If Hims & Hers updates any one or more forward-looking statements, no inference should be drawn that Hims & Hers will make additional updates with respect to those forward-looking statements. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. We caution you that forward-looking statements are not guarantees of future performance and that our actual results may differ materially from those made in or suggested by the forward-looking statements contained in this press release.
Closing brings the scale, technology and clinical infrastructure of Hims & Hers to Japan
